Dr Lahiri is a Senior Consultant, Divisions of Rheumatology and Advanced Internal Medicine at the National University Hospital, and Assistant Professor at the Yong Loo Lin School of Medicine, National University of Singapore. She is actively involved in education as the program director of the Rheumatology Senior Residency Program in NUH, and is the recipient of several teaching awards for undergraduate education. Dr Lahiri is the current Chair of the Chapter of Rheumatologists, College of Physicians, Academy of Medicine, Singapore since April 2019, and was formerly Vice-Chair from 2017 – 2019. During her tenure, she has led initiatives for the formulation of published recommendations for government subsidisation for biologic drugs for inflammatory arthritis, and for COVID-19 vaccination in people with rheumatic diseases.

    Dr Lahiri did her basic and postgraduate medical training in Internal Medicine at the prestigious All India Institute of Medical Sciences, New Delhi, India, and obtained membership of the Royal College of Physicians, UK in 2005. She was awarded the Ministry of Health – Health Manpower Development Program fellowship in 2010 to study Rheumatic disease epidemiology at the University of Manchester, UK, during which she won a best abstract award for her work, at the Annual European Congress of Rheumatology in 2011. Dr Lahiri’s research interests are in early arthritis and health care quality and services research. She has published on risk factors for early rheumatoid arthritis and is the Principal Investigator (PI) for the Singapore Early Arthritis Cohort (SEAC), former (inaugural) site PI and current Co-I for the Singapore National Biologics Register (SNBR) and overall PI for the Coronavirus National Vaccine registry for Immune diseases, Singapore (CONVIN-SING).